LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model- based approach

被引：5
|
作者：
Siddiqui, Salman H.
Pavord, Ian
Barnes, Neil C.
Lettis, Sally
Guasconi, Alessandro
Petruzzelli, Stefano
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Biomarkers; COPD; -; exacerbations;
D O I：
10.1183/13993003.congress-2016.OA1763
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1763
引用
收藏
页数：2
相关论文
共 2 条
  • [1] LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD
    Calverley, Peter M. A.
    Tetzlaff, Kay
    Vogelmeier, Claus
    Fabbri, Leonardo M.
    Magnussen, Helgo
    Wouters, Emiel F. M.
    Disse, Bernd
    Finnigan, Helen
    Asijee, Guus M.
    Watz, Henrik
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [2] Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
    Siddiqui, Salman H.
    Pavord, Ian D.
    Barnes, Neil C.
    Guasconi, Alessandro
    Lettis, Sally
    Pascoe, Steven
    Petruzzelli, Stefano
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3669 - 3676
1